» Articles » PMID: 34448786

COVID-19 Vaccines and Herd Immunity: Perspectives, Challenges and Prospects

Overview
Journal Malays J Pathol
Specialty Pathology
Date 2021 Aug 27
PMID 34448786
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The coronavirus disease 2019 (COVID-19) is one of the biggest public health threats in the 21st century. Nearly every country in the world has been affected by COVID-19. The magnitude of the problem, with over 179 million confirmed cases and 3.8 million deaths worldwide, has driven researchers to search for vaccines to combat the disease. The discovery and development of a new vaccine, from the initial stage to the vaccine finally reaching the patients, usually take many years. However, given the urgency of the situation, many clinical trials on the COVID-19 vaccines have been conducted at extraordinary speed, whereas several vaccines against SARS-CoV-2 are being administered worldwide. This article gives an overview of the different types of COVID-19 vaccines, with a focus on those with promising results and are commonly used worldwide. It also gives an overview of herd immunity and discusses the challenges in achieving herd immunity through the global vaccination campaigns. Last but not least, some strategies that may be used to address these challenges are discussed.

Citing Articles

Psychological antecedents of vaccine inequity: keys to improve the rates of vaccination.

Hussein M, Ibrahim S, Abdel-Rahman S, Elshabrawy A, Nasr H, Yazbek S J Egypt Public Health Assoc. 2024; 99(1):31.

PMID: 39627491 PMC: 11615162. DOI: 10.1186/s42506-024-00175-7.


Perceptions of the COVID-19 Vaccination Within a Convenience Sample of Sudanese Americans.

Freese J, Abuzaid F, Sayles H, Abdellatif M, Fadul N J Prim Care Community Health. 2024; 15():21501319241234868.

PMID: 38414263 PMC: 10900865. DOI: 10.1177/21501319241234868.


COVID-19 vaccine hesitancy: assessing the prevalence, predictors, and effectiveness of a community pharmacy based counseling intervention.

Kiptoo J, Isiiko J, Yadesa T, Rhodah T, Alele P, Mulogo E BMC Public Health. 2024; 24(1):111.

PMID: 38184570 PMC: 10771691. DOI: 10.1186/s12889-023-17532-4.


Comparative immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines: results of a pilot clinical study.

Stoma I, Korsak K, Voropaev E, Osipkina O, Kovalev A Heliyon. 2023; 9(11):e21877.

PMID: 38027828 PMC: 10658338. DOI: 10.1016/j.heliyon.2023.e21877.


An update on SARS-CoV-2 immunization and future directions.

Rana R, Kant R, Kumra T, Gupta S, Rana D, Ganguly N Front Pharmacol. 2023; 14:1125305.

PMID: 36969857 PMC: 10033701. DOI: 10.3389/fphar.2023.1125305.